Skip to main content

Shaker Benjamin's Form 4 filing

agilon health, inc. (AGL) · filed Jun 16, 2023

Accession no.
0001019056-23-000276
Filed
Jun 16, 2023
Trade date
Jun 14-15, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $699.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shaker BenjaminCIK 0001855843Officer (Chief Markets Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 14, 2023Common StockMOption exerciseAcquired+1,851$3.00+$5,55381,394Direct
Jun 14, 2023Common StockSSaleDisposed−1,851$17.93F3−$33,188.4379,543Direct
Jun 14, 2023Common StockMOption exerciseAcquired+15,799$3.79+$59,878.2195,342Direct
Jun 14, 2023Common StockSSaleDisposed−15,799$18.60F4−$293,861.479,543Direct
Jun 14, 2023Common StockMOption exerciseAcquired+1,100$3.79+$4,16980,643Direct
Jun 14, 2023Common StockSSaleDisposed−1,100$19.17F5−$21,08779,543Direct
Jun 15, 2023Common StockMOption exerciseAcquired+18,750$3.79+$71,062.598,293Direct
Jun 15, 2023Common StockSSaleDisposed−18,750$18.73F6−$351,187.579,543Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 14, 2023Common StockMOption exerciseDisposed−1,851$0.00$00Direct
Jun 14, 2023Common StockMOption exerciseDisposed−15,799$0.00$0434,201Direct
Jun 14, 2023Common StockMOption exerciseDisposed−1,100$0.00$0433,101Direct
Jun 15, 2023Common StockMOption exerciseDisposed−18,750$0.00$0414,351Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.665 to $18.040, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.040 to $19.030, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.055 to $19.295, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.2600 to $19.100, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)